Pfizer
Latest statistics and disclosures from Pfizer's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALLO, CELC, ARVN, PYXS, WVE, and represent 78.98% of Pfizer's stock portfolio.
- Reduced shares in these 4 stocks: ORIC (-$42M), ZURA (-$12M), QTTB, NXTC.
- Sold out of its position in QTTB.
- Pfizer was a net seller of stock by $-55M.
- Pfizer has $170M in assets under management (AUM), dropping by -28.65%.
- Central Index Key (CIK): 0000078003
Tip: Access up to 7 years of quarterly data
Positions held by Pfizer consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Pfizer
Pfizer holds 17 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Allogene Therapeutics (ALLO) | 27.5 | $47M | 22M | 2.13 |
|
|
| Celcuity (CELC) | 17.3 | $30M | 296k | 99.95 |
|
|
| Arvinas Ord (ARVN) | 16.2 | $28M | 3.5M | 8.00 |
|
|
| Pyxis Oncology Common Stock (PYXS) | 11.4 | $20M | 7.0M | 2.77 |
|
|
| Wave Life Sciences SHS (WVE) | 6.4 | $11M | 1.9M | 5.83 |
|
|
| Biohaven (BHVN) | 4.7 | $8.0M | 506k | 15.83 |
|
|
| Caribou Biosciences (CRBU) | 4.6 | $7.9M | 4.7M | 1.68 |
|
|
| Spero Therapeutics (SPRO) | 3.1 | $5.3M | 2.4M | 2.26 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 2.3 | $3.9M | 954k | 4.04 |
|
|
| Oric Pharmaceuticals (ORIC) | 2.1 | $3.6M | -92% | 373k | 9.53 |
|
| Cardiff Oncology (CRDF) | 1.8 | $3.0M | 2.4M | 1.25 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 1.7 | $2.9M | -81% | 539k | 5.35 |
|
| Agomab Therapeutics Nv Ads (AGMB) | 0.6 | $1.0M | 75k | 13.81 |
|
|
| Bolt Biotherapeutics Com New (BOLT) | 0.1 | $134k | 31k | 4.28 |
|
|
| Nextcure Com New (NXTC) | 0.0 | $73k | -71% | 44k | 1.65 |
|
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $30k | 2.9k | 10.25 |
|
|
| Senseonics Hldgs | 0.0 | $12k | 2.2k | 5.72 |
|
Past Filings by Pfizer
SEC 13F filings are viewable for Pfizer going back to 2025
- Pfizer 2026 Q2 filed Aug. 13, 2026
- Pfizer 2026 Q1 filed May 12, 2026
- Pfizer 2025 Q4 filed Feb. 12, 2026
- Pfizer 2025 Q3 filed Nov. 13, 2025
- Pfizer 2025 Q2 filed Aug. 11, 2025
- Pfizer 2025 Q1 filed May 13, 2025